UniProt ID | PP1RA_HUMAN | |
---|---|---|
UniProt AC | Q96QC0 | |
Protein Name | Serine/threonine-protein phosphatase 1 regulatory subunit 10 | |
Gene Name | PPP1R10 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 940 | |
Subcellular Localization | Nucleus . Found in discrete nucleoplasmic bodies and within nucleoli. Associates with chromatin during interphase, excluded from condensed chromosomes during early mitosis and is reloaded onto chromosomes at the late telophase (By similarity).. | |
Protein Description | Scaffold protein which mediates the formation of the PTW/PP1 phosphatase complex by providing a binding platform to each component of the complex. The PTW/PP1 phosphatase complex plays a role in the control of chromatin structure and cell cycle progression during the transition from mitosis into interphase. Mediates interaction of WDR82 and PPP1CA. Inhibitor of PPP1CA and PPP1CC phosphatase activities. Has inhibitory activity on PPP1CA only when phosphorylated. Binds to mRNA, single-stranded DNA (ssDNA), poly(A) and poly(G) homopolymers (By similarity).. | |
Protein Sequence | MGSGPIDPKELLKGLDSFLNRDGEVKSVDGISKIFSLMKEARKMVSRCTYLNILLQTRSPEILVKFIDVGGYKLLNNWLTYSKTTNNIPLLQQILLTLQHLPLTVDHLKQNNTAKLVKQLSKSSEDEELRKLASVLVSDWMAVIRSQSSTQPAEKDKKKRKDEGKSRTTLPERPLTEVKAETRAEEAPEKKREKPKSLRTTAPSHAKFRSTGLELETPSLVPVKKNASTVVVSDKYNLKPIPLKRQSNVAAPGDATPPAEKKYKPLNTTPNATKEIKVKIIPPQPMEGLGFLDALNSAPVPGIKIKKKKKVLSPTAAKPSPFEGKTSTEPSTAKPSSPEPAPPSEAMDADRPGTPVPPVEVPELMDTASLEPGALDAKPVESPGDPNQLTRKGRKRKSVTWPEEGKLREYFYFELDETERVNVNKIKDFGEAAKREILSDRHAFETARRLSHDNMEEKVPWVCPRPLVLPSPLVTPGSNSQERYIQAEREKGILQELFLNKESPHEPDPEPYEPIPPKLIPLDEECSMDETPYVETLEPGGSGGSPDGAGGSKLPPVLANLMGSMGAGKGPQGPGGGGINVQEILTSIMGSPNSHPSEELLKQPDYSDKIKQMLVPHGLLGPGPIANGFPPGGPGGPKGMQHFPPGPGGPMPGPHGGPGGPVGPRLLGPPPPPRGGDPFWDGPGDPMRGGPMRGGPGPGPGPYHRGRGGRGGNEPPPPPPPFRGARGGRSGGGPPNGRGGPGGGMVGGGGHRPHEGPGGGMGNSSGHRPHEGPGGGMGSGHRPHEGPGGSMGGGGGHRPHEGPGGGISGGSGHRPHEGPGGGMGAGGGHRPHEGPGGSMGGSGGHRPHEGPGHGGPHGHRPHDVPGHRGHDHRGPPPHEHRGHDGPGHGGGGHRGHDGGHSHGGDMSNRPVCRHFMMKGNCRYENNCAFYHPGVNGPPLP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
3 | Phosphorylation | -----MGSGPIDPKE -----CCCCCCCHHH | 39.85 | 30631047 | |
13 | Ubiquitination | IDPKELLKGLDSFLN CCHHHHHHHHHHHHC | 70.79 | 21890473 | |
26 | Acetylation | LNRDGEVKSVDGISK HCCCCCCCCHHHHHH | 40.22 | 26051181 | |
27 | Phosphorylation | NRDGEVKSVDGISKI CCCCCCCCHHHHHHH | 30.53 | 21406692 | |
32 | Phosphorylation | VKSVDGISKIFSLMK CCCHHHHHHHHHHHH | 25.81 | 20068231 | |
33 | Acetylation | KSVDGISKIFSLMKE CCHHHHHHHHHHHHH | 45.94 | 26051181 | |
33 | Ubiquitination | KSVDGISKIFSLMKE CCHHHHHHHHHHHHH | 45.94 | 21890473 | |
36 | Phosphorylation | DGISKIFSLMKEARK HHHHHHHHHHHHHHH | 30.90 | 20068231 | |
39 | Acetylation | SKIFSLMKEARKMVS HHHHHHHHHHHHHHH | 54.22 | 25953088 | |
49 | Phosphorylation | RKMVSRCTYLNILLQ HHHHHHHHHHHHHHH | 29.90 | 22210691 | |
57 | Phosphorylation | YLNILLQTRSPEILV HHHHHHHCCCHHHEE | 32.84 | 22210691 | |
115 | Acetylation | LKQNNTAKLVKQLSK HHHCCHHHHHHHHHC | 52.34 | 25953088 | |
118 | Acetylation | NNTAKLVKQLSKSSE CCHHHHHHHHHCCCC | 56.83 | 27452117 | |
118 | Ubiquitination | NNTAKLVKQLSKSSE CCHHHHHHHHHCCCC | 56.83 | - | |
121 | Phosphorylation | AKLVKQLSKSSEDEE HHHHHHHHCCCCHHH | 28.18 | 30624053 | |
134 | Phosphorylation | EELRKLASVLVSDWM HHHHHHHHHHHHHHH | 26.81 | - | |
138 | Phosphorylation | KLASVLVSDWMAVIR HHHHHHHHHHHHHHH | 22.76 | - | |
149 | Phosphorylation | AVIRSQSSTQPAEKD HHHHHCCCCCCCCHH | 24.35 | - | |
150 | Phosphorylation | VIRSQSSTQPAEKDK HHHHCCCCCCCCHHH | 43.76 | - | |
168 | Phosphorylation | KDEGKSRTTLPERPL HCCCCCCCCCCCCCC | 39.51 | 28555341 | |
179 | Sumoylation | ERPLTEVKAETRAEE CCCCCHHHHHHHHHH | 33.98 | - | |
179 | Sumoylation | ERPLTEVKAETRAEE CCCCCHHHHHHHHHH | 33.98 | 17000644 | |
200 | Phosphorylation | EKPKSLRTTAPSHAK CCCCCCCCCCCCCHH | 32.38 | 30576142 | |
207 | Acetylation | TTAPSHAKFRSTGLE CCCCCCHHHHCCCCE | 35.57 | 19608861 | |
207 | Ubiquitination | TTAPSHAKFRSTGLE CCCCCCHHHHCCCCE | 35.57 | 19608861 | |
211 | Phosphorylation | SHAKFRSTGLELETP CCHHHHCCCCEEECC | 41.34 | 28555341 | |
217 | Phosphorylation | STGLELETPSLVPVK CCCCEEECCCEEECC | 30.70 | 28555341 | |
224 | Acetylation | TPSLVPVKKNASTVV CCCEEECCCCCCEEE | 33.95 | 25953088 | |
236 | Phosphorylation | TVVVSDKYNLKPIPL EEEEECCCCCEECCC | 30.62 | - | |
239 | Acetylation | VSDKYNLKPIPLKRQ EECCCCCEECCCCCC | 36.94 | 23236377 | |
239 | Ubiquitination | VSDKYNLKPIPLKRQ EECCCCCEECCCCCC | 36.94 | 21890473 | |
244 | Acetylation | NLKPIPLKRQSNVAA CCEECCCCCCCCCCC | 42.93 | 25953088 | |
244 | Methylation | NLKPIPLKRQSNVAA CCEECCCCCCCCCCC | 42.93 | 69475 | |
247 | Phosphorylation | PIPLKRQSNVAAPGD ECCCCCCCCCCCCCC | 36.99 | 30266825 | |
256 | Phosphorylation | VAAPGDATPPAEKKY CCCCCCCCCCHHHCC | 34.25 | 30266825 | |
261 | Acetylation | DATPPAEKKYKPLNT CCCCCHHHCCCCCCC | 64.61 | 23749302 | |
262 | Acetylation | ATPPAEKKYKPLNTT CCCCHHHCCCCCCCC | 50.43 | 30583163 | |
262 | Sumoylation | ATPPAEKKYKPLNTT CCCCHHHCCCCCCCC | 50.43 | 28112733 | |
263 | Phosphorylation | TPPAEKKYKPLNTTP CCCHHHCCCCCCCCC | 28.98 | 29396449 | |
264 | Acetylation | PPAEKKYKPLNTTPN CCHHHCCCCCCCCCC | 52.49 | 26051181 | |
268 | Phosphorylation | KKYKPLNTTPNATKE HCCCCCCCCCCCCCE | 51.84 | 21712546 | |
269 | Phosphorylation | KYKPLNTTPNATKEI CCCCCCCCCCCCCEE | 17.30 | 25159151 | |
273 | Phosphorylation | LNTTPNATKEIKVKI CCCCCCCCCEEEEEE | 35.53 | 22199227 | |
274 | Acetylation | NTTPNATKEIKVKII CCCCCCCCEEEEEEC | 55.84 | 23749302 | |
274 | Ubiquitination | NTTPNATKEIKVKII CCCCCCCCEEEEEEC | 55.84 | 19608861 | |
297 | Phosphorylation | GFLDALNSAPVPGIK CHHHHHHCCCCCCCE | 34.50 | 20068231 | |
313 | Phosphorylation | KKKKKVLSPTAAKPS CCCCEECCCCCCCCC | 24.16 | 29255136 | |
315 | Phosphorylation | KKKVLSPTAAKPSPF CCEECCCCCCCCCCC | 35.55 | 22167270 | |
318 | Acetylation | VLSPTAAKPSPFEGK ECCCCCCCCCCCCCC | 43.49 | 26051181 | |
320 | Phosphorylation | SPTAAKPSPFEGKTS CCCCCCCCCCCCCCC | 41.33 | 23927012 | |
326 | Phosphorylation | PSPFEGKTSTEPSTA CCCCCCCCCCCCCCC | 52.30 | 26074081 | |
327 | Phosphorylation | SPFEGKTSTEPSTAK CCCCCCCCCCCCCCC | 33.97 | 26074081 | |
328 | Phosphorylation | PFEGKTSTEPSTAKP CCCCCCCCCCCCCCC | 58.09 | 26074081 | |
331 | Phosphorylation | GKTSTEPSTAKPSSP CCCCCCCCCCCCCCC | 34.46 | 26074081 | |
332 | Phosphorylation | KTSTEPSTAKPSSPE CCCCCCCCCCCCCCC | 49.79 | 26074081 | |
336 | Phosphorylation | EPSTAKPSSPEPAPP CCCCCCCCCCCCCCC | 58.79 | 28387310 | |
337 | Phosphorylation | PSTAKPSSPEPAPPS CCCCCCCCCCCCCCH | 41.64 | 28387310 | |
344 | Phosphorylation | SPEPAPPSEAMDADR CCCCCCCHHHCCCCC | 36.61 | 26074081 | |
354 | Phosphorylation | MDADRPGTPVPPVEV CCCCCCCCCCCCCCC | 24.64 | 26074081 | |
367 | Phosphorylation | EVPELMDTASLEPGA CCCCCCCCCCCCCCC | 12.27 | 26074081 | |
369 | Phosphorylation | PELMDTASLEPGALD CCCCCCCCCCCCCCC | 35.04 | 26074081 | |
382 | Phosphorylation | LDAKPVESPGDPNQL CCCCCCCCCCCHHHC | 34.12 | 19664994 | |
390 | Phosphorylation | PGDPNQLTRKGRKRK CCCHHHCCCCCCCCC | 22.14 | 26552605 | |
398 | Phosphorylation | RKGRKRKSVTWPEEG CCCCCCCCCCCCCCC | 28.89 | 25159151 | |
400 | Phosphorylation | GRKRKSVTWPEEGKL CCCCCCCCCCCCCCE | 42.25 | 19691289 | |
406 | Acetylation | VTWPEEGKLREYFYF CCCCCCCCEEEEEEE | 47.88 | 25953088 | |
425 | 2-Hydroxyisobutyrylation | TERVNVNKIKDFGEA CCCCCHHHHHHHHHH | 47.02 | - | |
441 | Methylation | KREILSDRHAFETAR HHHHHCCHHHHHHHH | 21.47 | 115488023 | |
451 | Phosphorylation | FETARRLSHDNMEEK HHHHHHHCCCCHHHC | 27.30 | 24247654 | |
471 | Phosphorylation | PRPLVLPSPLVTPGS CCCEECCCCCCCCCC | 27.06 | 29255136 | |
475 | Phosphorylation | VLPSPLVTPGSNSQE ECCCCCCCCCCCHHH | 29.61 | 23312004 | |
491 | Ubiquitination | YIQAEREKGILQELF HHHHHHHHCHHHHHH | 58.43 | - | |
501 | Ubiquitination | LQELFLNKESPHEPD HHHHHCCCCCCCCCC | 62.81 | - | |
503 | Phosphorylation | ELFLNKESPHEPDPE HHHCCCCCCCCCCCC | 32.92 | 24719451 | |
527 | Phosphorylation | IPLDEECSMDETPYV CCCCCCCCCCCCCCE | 32.33 | 20873877 | |
531 | Phosphorylation | EECSMDETPYVETLE CCCCCCCCCCEEECC | 18.69 | 20873877 | |
533 | Phosphorylation | CSMDETPYVETLEPG CCCCCCCCEEECCCC | 20.52 | 20873877 | |
536 | Phosphorylation | DETPYVETLEPGGSG CCCCCEEECCCCCCC | 26.78 | 30576142 | |
542 | Phosphorylation | ETLEPGGSGGSPDGA EECCCCCCCCCCCCC | 45.99 | 30278072 | |
545 | Phosphorylation | EPGGSGGSPDGAGGS CCCCCCCCCCCCCCC | 24.28 | 30278072 | |
552 | Phosphorylation | SPDGAGGSKLPPVLA CCCCCCCCCCCHHHH | 30.06 | 30278072 | |
586 | Phosphorylation | INVQEILTSIMGSPN CCHHHHHHHHHCCCC | 23.13 | 17081983 | |
587 | Phosphorylation | NVQEILTSIMGSPNS CHHHHHHHHHCCCCC | 13.72 | 25159151 | |
591 | Phosphorylation | ILTSIMGSPNSHPSE HHHHHHCCCCCCCCH | 11.97 | 25159151 | |
594 | Phosphorylation | SIMGSPNSHPSEELL HHHCCCCCCCCHHHH | 39.91 | 21712546 | |
597 | Phosphorylation | GSPNSHPSEELLKQP CCCCCCCCHHHHHCC | 37.98 | 24300666 | |
602 | Ubiquitination | HPSEELLKQPDYSDK CCCHHHHHCCCCHHH | 72.85 | - | |
606 | Phosphorylation | ELLKQPDYSDKIKQM HHHHCCCCHHHHHHH | 26.00 | 26074081 | |
607 | Phosphorylation | LLKQPDYSDKIKQML HHHCCCCHHHHHHHH | 39.55 | 26074081 | |
609 | Ubiquitination | KQPDYSDKIKQMLVP HCCCCHHHHHHHHCC | 45.95 | - | |
665 | Dimethylation | PGGPVGPRLLGPPPP CCCCCCHHHCCCCCC | 36.29 | - | |
665 | Methylation | PGGPVGPRLLGPPPP CCCCCCHHHCCCCCC | 36.29 | 24129315 | |
674 | Dimethylation | LGPPPPPRGGDPFWD CCCCCCCCCCCCCCC | 68.45 | - | |
674 | Methylation | LGPPPPPRGGDPFWD CCCCCCCCCCCCCCC | 68.45 | 30762913 | |
688 | Methylation | DGPGDPMRGGPMRGG CCCCCCCCCCCCCCC | 52.91 | 54558187 | |
693 | Methylation | PMRGGPMRGGPGPGP CCCCCCCCCCCCCCC | 50.48 | 24129315 | |
705 | Methylation | PGPGPYHRGRGGRGG CCCCCCCCCCCCCCC | 30.57 | 24411411 | |
707 | Methylation | PGPYHRGRGGRGGNE CCCCCCCCCCCCCCC | 44.33 | 54558195 | |
710 | Methylation | YHRGRGGRGGNEPPP CCCCCCCCCCCCCCC | 53.31 | 54558211 | |
723 | Methylation | PPPPPPFRGARGGRS CCCCCCCCCCCCCCC | 43.57 | 54558179 | |
726 | Methylation | PPPFRGARGGRSGGG CCCCCCCCCCCCCCC | 51.42 | 54558203 | |
729 | Methylation | FRGARGGRSGGGPPN CCCCCCCCCCCCCCC | 34.65 | 54558219 | |
738 | Methylation | GGGPPNGRGGPGGGM CCCCCCCCCCCCCCC | 54.24 | - | |
764 | Phosphorylation | PGGGMGNSSGHRPHE CCCCCCCCCCCCCCC | 31.78 | 22210691 | |
765 | Phosphorylation | GGGMGNSSGHRPHEG CCCCCCCCCCCCCCC | 42.49 | 22210691 | |
779 | Phosphorylation | GPGGGMGSGHRPHEG CCCCCCCCCCCCCCC | 23.64 | 26552605 | |
790 | Phosphorylation | PHEGPGGSMGGGGGH CCCCCCCCCCCCCCC | 21.85 | 26552605 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PP1RA_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
398 | S | Phosphorylation |
| 23186163 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PP1RA_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
WDR82_HUMAN | WDR82 | physical | 20516061 | |
PP1A_HUMAN | PPP1CA | physical | 20516061 | |
PP1B_HUMAN | PPP1CB | physical | 20516061 | |
PP1G_HUMAN | PPP1CC | physical | 20516061 | |
TOX4_HUMAN | TOX4 | physical | 20516061 | |
PP1RA_HUMAN | PPP1R10 | physical | 20516061 | |
HSP74_HUMAN | HSPA4 | physical | 20516061 | |
PP1A_HUMAN | PPP1CA | physical | 12574161 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-207 AND LYS-239, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-545, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-313 AND SER-591, ANDMASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-313, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-313, AND MASSSPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-256, AND MASSSPECTROMETRY. |